首页 | 本学科首页   官方微博 | 高级检索  
   检索      

HA纳米载体介导转hGM-CSF基因的HepG2疫苗诱导的抗瘤效应研究
引用本文:曾治中,段晓明,程元星,黄璐,贺修胜.HA纳米载体介导转hGM-CSF基因的HepG2疫苗诱导的抗瘤效应研究[J].生物磁学,2011(4):672-676,671.
作者姓名:曾治中  段晓明  程元星  黄璐  贺修胜
作者单位:[1]南华大学研究生院,湖南衡阳421001 [2]长沙市第四医院消化内科,湖南长沙410006 [3]南华大学肿瘤研究所,湖南衡阳421001
基金项目:湖南省卫生厅科研基金资助项目(B2005-178)
摘    要:目的:观察HA纳米颗粒载体介导转染hGM-CSF基因的HepG2细胞疫苗体外抗肿瘤效应,为hGM-CSF基因修饰的HepG2细胞疫苗的临床应用提供依据。方法:HA纳米颗粒载体介导hGM-CSF基因转染HepG2细胞制备转GMCSF基因的HepG2细胞疫苗。密度梯度离心法分离人PBMC,体外诱导人PBMC。WST-1法测定PBMC的增殖活性及对HepG2细胞的杀伤效应,流式细胞术分析CD4+和CD8+的阳性表达率,ELISA法测定INF-γ的分泌。结果:WST-1结果显示,转基因HepG2组疫苗能诱导PBMC增殖,其增殖率优于野生型疫苗(p〈0.05);其诱导的PBMC对HepG2的杀伤率高于各野生型疫苗组和各空白对照组(p〈0.05)。FCM结果显示,转基因HepG2疫苗组PBMC中CD4+和CD8+阳性表达率均高于各野生型疫苗组和各空白对照组(p〈0.05)。ELISA结果显示,转基因组PBMC培养上清中IFN-γ含量为1989.76±254.21pg/ml,高于各野生型疫苗组和各空白对照组(p〈0.05)。结论:HA纳米颗粒载体介导转染hGM-CSF基因能增加HepG2细胞疫苗的免疫原性,转hGM-CSF基因HepG2细胞疫苗可有效诱导PBMC增殖、分化,增加INF-γ的分泌,提高其对HepG2细胞的杀伤作用。

关 键 词:肝肿瘤  肿瘤疫苗  免疫治疗  粒细胞巨噬细胞集落刺激因子  外周血单个核细胞

Anti-tumor effects of HepG2 tumor vaccine transfected hGM-CSF gene mediated by HA nanoparticles
ZENG Zhi-zhong,DUAN Xiao-ming,CHENG Yuan-xing,HUANG Lu,HE Xiu-sheng.Anti-tumor effects of HepG2 tumor vaccine transfected hGM-CSF gene mediated by HA nanoparticles[J].Biomagnetism,2011(4):672-676,671.
Authors:ZENG Zhi-zhong  DUAN Xiao-ming  CHENG Yuan-xing  HUANG Lu  HE Xiu-sheng
Institution:1 Postgraduate Institute,Nanhua University,Hengyang 421001,China; 2 Department of Gastroenterology,Fouth Hospital of Changsha,Changsha 410004,China; 3 The Cancer Research Institute of Nanhua University,Hengyang 421001,China)
Abstract:Objective:To observe the HA Nanoparticles mediated transfection of hGM-CSF gene in HepG2 cells in vitro anti-tu-mor effect of the vaccine for the hGM-CSF gene-modified vaccine HepG2 cells provide the basis for clinical application.Methods:HA nanoparticles mediated gene transfer hGM-CSF preparation of HepG2 cells HepG2 cells transfected GMCSF gene vaccine.Density gra-dient centrifugation were PBMC,in vitro induction of human PBMC.WST-1 method PBMC proliferation activity and killing effect on HepG2 cells,flow cytometry analysis of CD4+and CD8+ positive expression rates,ELISA determination of INF-γ secretion.Results:WST-1 showed that transgenic HepG2 group of vaccine induced PBMC proliferation,the proliferation rate than wild-type vaccine(p0.05).The PBMC of the HepG2 induced high anti-vaccine groups in the wild type and the control group(p0.05).FCM results showed that transgenic HepG2 PBMC in the vaccine group CD4+and CD8+expression was higher than the wild-type vaccine group and con-trol group(p0.05).ELISA results showed that the transgenic group PBMC supernatants of IFN-γ content was 1989.76±254.21 pg/ml,higher than the wild-type vaccine group and control group(p0.05).Conclusion:HA nanoparticles mediated transfection of hGM-CSF gene can increase the immunogenicity of the vaccine HepG2 cells,transfected HepG2 cells in hGM-CSF gene vaccine can effectively induce PBMC proliferation,differentiation,increased INF-γ secretion,increase its HepG2 cells in vitro.
Keywords:liver neoplasms  tumor vaccine  immune therapy  granulocyte-macrophage colony-stimulating factor  peripheral blood mononuclear cells
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号